Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-O-methyltransferase Inhibitors and Substrates

[Image: see text] Reduced dopamine neurotransmission in the prefrontal cortex has been implicated as causal for the negative symptoms and cognitive deficit associated with schizophrenia; thus, a compound which selectively enhances dopamine neurotransmission in the prefrontal cortex may have therapeu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Robinson, Ronald G., Smith, Sean M., Wolkenberg, Scott E., Kandebo, Monika, Yao, Lihang, Gibson, Christopher R., Harrison, Scott T., Polsky-Fisher, Stacey, Barrow, James C., Manley, Peter J., Mulhearn, James J., Nanda, Kausik K., Schubert, Jeffrey W., Trotter, B. Wesley, Zhao, Zhijian, Sanders, John M., Smith, Robert F., McLoughlin, Debra, Sharma, Sujata, Hall, Dawn L., Walker, Tiffany L., Kershner, Jennifer L., Bhandari, Neetesh, Hutson, Pete H., Sachs, Nancy A.
Formato: Artigo
Idioma:Inglês
Publicado: American Chemical Society 2011
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3369789/
https://ncbi.nlm.nih.gov/pubmed/22860182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn200109w
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares